Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Original paper

Researched by:

  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

November 24, 2025

Researched by:

  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

Last Updated: 2020-01-01

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Location
China
Sample Site
Feces
Saliva
Species
Homo sapiens

What was studied

This study examined dysbiosis of the saliva microbiome in polycystic ovary syndrome (PCOS), with emphasis on how microbiota behavior—including diurnal oscillation—differs between affected and healthy women. The focus keyphrase saliva microbiome in PCOS is central here because the investigators explored microbial signatures, taxonomic shifts, and predicted functional changes across four time points over 24 hours. Using 16S rRNA gene sequencing, the researchers mapped salivary and fecal bacterial communities to determine whether PCOS alters microbial diversity, abundance, rhythmicity, and pathway-level characteristics. Their working hypothesis was that circadian oscillations known to occur in healthy salivary microbiota are disrupted in PCOS, which could contribute to local and systemic disease risk.

Who was studied

The cohort included 10 women with PCOS diagnosed by Rotterdam criteria and 10 healthy controls, ages 18–45, all of whom followed standardized dietary guidelines and avoided antibiotics, probiotics, smoking, alcohol, and oral disease that might confound oral microbial signatures. Four saliva samples (ZT0, ZT6, ZT12, ZT18) and one fecal sample per participant were collected under controlled inpatient conditions. The groups were comparable in age and BMI, although PCOS participants exhibited characteristic hormonal alterations, including higher total testosterone and LH/FSH ratios.

Most important findings

PCOS markedly altered the saliva microbiome at every time point. Alpha diversity was significantly reduced at ZT0, while beta-diversity analyses showed distinct clustering between PCOS and controls at ZT0 and ZT18. Across pages 3–5, figures show consistent enrichment of the phylum Fusobacteria and genus Fusobacterium in PCOS saliva at all time points, a microbe linked to inflammation, periodontal disease, metabolic dysfunction, and obesity. LEfSe analysis revealed decreased Actinobacteria and Leptotrichia at multiple time points, alongside gains in taxa such as Gracilibacteria and Clostridiales, depending on the sampling period. These patterns suggest microbial instability, loss of beneficial commensals, and potential overrepresentation of inflammatory contributors. Functional predictions showed recurring upregulation of methane metabolism and downregulation of chaperones, folding catalysts, membrane structural molecules, and secretion systems—changes suggesting impaired microbial protein handling and increased fermentation potential. Several pathways fluctuated rhythmically in healthy controls but not in PCOS, supporting disrupted microbial chronobiology. Diurnal oscillation analysis revealed that taxa such as Proteobacteria, Bacteroidetes, Actinobacteria, Lactobacillales, Prevotellaceae, and Bacteroidales displayed significant rhythmicity in controls but largely lost rhythmic patterns in PCOS. Fecal microbiota, by contrast, showed no consistent PCOS-specific signature, underscoring compartment-specific dysbiosis.

Key implications

Disrupted diurnal rhythm of salivary microbiota in PCOS suggests a chronobiological dimension to disease pathophysiology. Increased Fusobacteria and reduced beneficial taxa may contribute to chronic inflammation, periodontal disease risk, and metabolic dysfunction. The findings highlight the relevance of oral microbiome assessment—and timing of sampling—for understanding systemic features of PCOS and refining microbiome-based clinical tools.

Citation

Li N, Li Y, Qian C, et al. Dysbiosis of the saliva microbiome in patients with polycystic ovary syndrome.Front Cell Infect Microbiol. 2021;10:624504. doi:10.3389/fcimb.2020.624504

Polycystic ovary syndrome (PCOS)

Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects women of reproductive age, characterized by irregular menstrual cycles, hyperandrogenism, and insulin resistance. It is often associated with metabolic dysfunctions and inflammation, leading to fertility issues and increased risk of type 2 diabetes and cardiovascular disease.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.